---
schema_version: "secwatch.filing_event.v1"
accession: "0001649094-25-000084"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T04:40:19.510103+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte shareholders re-elect all three Class II directors and approve officer exculpation

## Summary
- John Furey reelected with 120.7M For vs 0.4M Withheld; Jacks Lee 107.3M For vs 13.8M Withheld.
- Heath Lukatch, Ph.D. reelected with 99.2M For vs 21.9M Withheld.
- Deloitte & Touche ratified as auditor for FY2025 with 124.8M For, 0.2M Against.
- Advisory say-on-pay passed with 77.1M For, 44.0M Against, 4.0M broker non-votes.
- Amendment to certificate for officer exculpation approved with 112.3M For, 8.8M Against.

## SEC filing metadata
- accession: 0001649094-25-000084
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000084/0001649094-25-000084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000084/pcvx-20250612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001649094-25-000084
- JSON: https://secwatch.observer/filing/0001649094-25-000084.json
- Plain text: https://secwatch.observer/filing/0001649094-25-000084.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.